Greenwich Lifesciences Inc (GLSI) — Tangible Net Worth Ratio
Greenwich Lifesciences Inc (GLSI) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($5.27 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See net assets of Greenwich Lifesciences Inc for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Greenwich Lifesciences Inc Tangible Net Worth Ratio (2020–2024)
This chart shows how Greenwich Lifesciences Inc's Tangible Net Worth Ratio has changed across 5 annual periods from 2020 to 2024. As of March 2026, the ratio stands at 100.0%, reflecting net assets of $5.27 Million with intangible assets of $0.00 USD. Also explore GLSI net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Greenwich Lifesciences Inc (2020–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Greenwich Lifesciences Inc from 2020 to 2024, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Greenwich Lifesciences Inc.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.9% | $2.53 Million | $1.78K | $4.09 Million | ▲ +0.0 pp |
| 2023 | 99.9% | $6.70 Million | $5.39K | $6.99 Million | ▼ 0.0 pp |
| 2022 | 99.9% | $13.21 Million | $9.00K | $13.48 Million | ▼ 0.0 pp |
| 2021 | 100.0% | $26.83 Million | $12.62K | $27.22 Million | ▲ +0.0 pp |
| 2020 | 99.9% | $27.63 Million | $16.23K | $28.68 Million | — |